Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Sagent Pharmaceuticals

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on 12/15/2021.

Shortage Details

Status
Current
Company
Sagent Pharmaceuticals
Package NDC
25021-820-10
Dosage Form
Injection
Presentation
Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10)
Initial Posting
12/15/2021
Revised Date